Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling
Yangping Shentu, Yuyang Li, Shicheng Xie, Huanchang Jiang, Shicheng Sun, Rixu Lin, Chaosheng Chen, Yongheng Bai, Yu Zhang, Chenfei Zheng, Ying Zhou
Topics & Concepts
SMADEmpagliflozinFibrosisMedicineDownregulation and upregulationPeritoneal dialysisExtracellular matrixEndocrinologyPharmacologyTransforming growth factorInternal medicineCancer researchChemistryCell biologyBiologyBiochemistryType 2 diabetesDiabetes mellitusGeneDialysis and Renal Disease ManagementParathyroid Disorders and TreatmentsPancreatitis Pathology and Treatment